News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News TCT 2019 AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups Todd Neale September 26, 2019
News Conference News TCT 2018 Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos Michael O'Riordan October 02, 2018
News Conference News TCT 2018 OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients Todd Neale September 24, 2018
News Conference News TCT 2016 ‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent Todd Neale October 31, 2016
News Conference News TCT 2015 Discussion Highlights Merits, Limitations of Small Trials Yael L. Maxwell October 13, 2015
News Conference News TCT 2014 Thoughtful Insights at TCT: Uncertainty Surrounds Antithrombotic Therapy in PCI Patients Who Require Anticoagulation Todd Neale October 10, 2014
News Conference News TCT 2014 Skeptic’s Corner: Experts Debate Aspirin Use in Patients with AF Receiving DES Todd Neale September 13, 2014
News Conference News TCT 2013 Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias November 04, 2013
News Conference News TCT 2013 Data Evolving for Pharmacological Treatment Strategies for Patients with AF and Valvular Heart Disease October 29, 2013
News Conference News TCT 2012 Aspirin, Cilostazol Combination Best After Angioplasty for Critical Limb Ischemia November 01, 2012
News Conference News TCT 2012 FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy October 24, 2012